Delivery Order SPE2DB24D3014-SPE2DB25FKUSU
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $24,386.37 delivery order for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $36,985.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pharmaceutical products, with a completion date of September 9, 2025. The contract, issued on September 8, 2025, is a non-set-aside competitive award with performance in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $20,564.59 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's critical role as a pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors, with a contract ceiling value of $47,910.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This competitively awarded, non-set-aside contract carries a ceiling value of $9,476.47 under firm fixed-price terms, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $34,017.92 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors under a firm fixed-price contract on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside award represents a routine pharmaceutical procurement supporting military healthcare needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and fulfill this...
- The Defense Logistics Agency awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 19, 2025. This non-competitive delivery order represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. The award was made to AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors, with a ceiling value of $11,222.37. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a $27,570.72 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract utilizes firm fixed pricing with no set-aside designation and is classified as a child contract under a larger vehicle. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $76,320.35 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, which carries an ultimate completion date of September 19, 2025, was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKUSUDelivery Order
The Defense Logistics Agency awarded a $13,801.29 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical supply needs through open competition, ranging from low-value transactions to substantial orders exceeding $45,000. The DLA's Pharmaceutical Prime Vendor Global Program Generation V procurement strategy plans to establish multiple regional contracts with separate contractors, positioning AmerisourceBergen among the key vendors supporting military and federal healthcare supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 9/18/25 |